These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4351976)

  • 1. Responses of gibbons to inoculation of Epstein-Barr virus.
    Werner J; Pinto CA; Haff RF; Henle W; Henle G
    J Infect Dis; 1972 Dec; 126(6):678-81. PubMed ID: 4351976
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishment of continuous lymphoblast cultures from leukocytes of gibbons (Hylobates lar).
    Werner J; Henle G; Pinto CA; Haff RF; Henle W
    Int J Cancer; 1972 Nov; 10(3):557-67. PubMed ID: 4358039
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis.
    Britton S; Andersson-Anvret M; Gergely P; Henle W; Jondal M; Klein G; Sandstedt B; Svedmyr E
    N Engl J Med; 1978 Jan; 298(2):89-92. PubMed ID: 201839
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
    Hewetson JF; Rocchi G; Henle W; Henle G
    J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.
    Miller G; Niederman JC; Andrews LL
    N Engl J Med; 1973 Feb; 288(5):229-32. PubMed ID: 4345064
    [No Abstract]   [Full Text] [Related]  

  • 6. [Detection of Epstein-Barr virus in the tonsils in infectious mononucleosis].
    Sauerbrei A; Färber I; Wutzler P; Swoboda R; Schneider J
    Laryngorhinootologie; 1990 Feb; 69(2):70-3. PubMed ID: 2157451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.
    Lai PK; Mackay-Scollay EM; Fimmel PJ; Alpers MP; Keast D
    Nature; 1974 Dec; 252(5484):608-10. PubMed ID: 4372559
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoic cell lines and in the blood of patients with infectious mononucleosis.
    Greaves MF; Brown G
    Clin Immunol Immunopathol; 1975 Mar; 3(4):514-24. PubMed ID: 163715
    [No Abstract]   [Full Text] [Related]  

  • 9. Epstein-Barr virus and nonhuman primates: natural and experimental infection.
    Frank A; Andiman WA; Miller G
    Adv Cancer Res; 1976; 23():171-201. PubMed ID: 179290
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
    Hewetson JF; Gothoskar B; Klein G
    J Natl Cancer Inst; 1972 Jan; 48(1):87-94. PubMed ID: 4347031
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the antibodies to Epstein-Barr virus capsid antigen in the diagnosis of infectious mononucleosis in children].
    Krotochwil-Skrzypkowa M; Najberg G
    Pediatr Pol; 1982; 57(9):633-43. PubMed ID: 6302631
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Miller G; Lipman M
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Epstein-Barr Virus and Infectious Mononucleosis. Findings, interpretations, and an alternative hypothesis on the direct etiology by the Epstein-Barr Virus].
    Gsell HO
    Schweiz Med Wochenschr; 1971 Jun; 101(23):841-8. PubMed ID: 4325374
    [No Abstract]   [Full Text] [Related]  

  • 14. Epstein-Barr virus antibody and lymphocyte tubuloreticular structures in systemic lupus erythematosus.
    Klippel JH; Decker JL
    Lancet; 1973 Nov; 2(7837):1057-8. PubMed ID: 4127314
    [No Abstract]   [Full Text] [Related]  

  • 15. A synthetic peptide for detecting antibodies to Epstein-Barr virus nuclear antigen in sera from patients with infectious mononucleosis.
    Smith RS; Rhodes G; Vaughan JH; Horwitz CA; Geltosky JE; Whalley AS
    J Infect Dis; 1986 Nov; 154(5):885-9. PubMed ID: 3021871
    [No Abstract]   [Full Text] [Related]  

  • 16. Infectious mononucleosis: appearance of neutralizing antibody to Epstein-Barr virus measured by inhibition of formation of lymphoblastoid cell lines.
    Miller G; Niederman JC; Stitt DA
    J Infect Dis; 1972 Apr; 125(4):403-6. PubMed ID: 4336201
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis.
    Horwitz CA; Henle W; Henle G; Rudnick H; Latts E
    J Infect Dis; 1985 Jun; 151(6):1150-3. PubMed ID: 2987370
    [No Abstract]   [Full Text] [Related]  

  • 18. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV.
    Ishida T; Yamamoto K
    J Med Primatol; 1987; 16(6):359-71. PubMed ID: 2828628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative detection of herpesviruses in tissue specimens by in situ hybridization and immunofluorescence.
    Sauerbrei A; Wutzler P; Färber I; Brichácek B; Swoboda R; Macheleidt S
    Acta Virol; 1986 May; 30(3):213-9. PubMed ID: 2874725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infections.
    Middleton PJ
    Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.